[1]
JACOB BUNU, S. et al. 2020. CLINICAL RELEVANCE OF EFAVIRENZ PHARMACOKINETICS AND PHARMACOGENETICS IN HIV/AIDS THERAPY. Asian Journal of Pharmaceutical and Clinical Research. 13, 6 (Jun. 2020), 26–30. DOI:https://doi.org/10.22159/ajpcr.2020.v13i6.37405.